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Abstract objectives To assess the population prevalence of malaria in villages across Papua New Guinea
(PNG) following the first roll-out of free long-lasting insecticidal nets (LLIN).
methods Between October 2008 and August 2009, a household survey was conducted in 49
random villages in districts covered by the LLIN distribution campaign. The survey extended to 19
villages in sentinel sites that had not yet been covered by the campaign. In each village, 30
households were randomly sampled, household heads were interviewed and capillary blood samples
were collected from all consenting household members for microscopic diagnosis of malaria.
results Malaria prevalence ranged from 0% to 49.7% with a weighted average of 12.1% (95% CI
9.5, 15.3) in the national sample. More people were infected with Plasmodium falciparum (7.0%;
95% CI 5.4, 9.1) than with P. vivax (3.8%; 95% CI 2.4, 5.7) or P. malariae (0.3%; 95% CI 0.1,
0.6). Parasitaemia was strongly age-dependent with a P. falciparum peak at age 5–9 years and a
P. vivax peak at age 1–4 years, yet with differences between geographical regions. Individual LLIN
use and high community coverage were associated with reduced odds of infection (OR = 0.64 and
0.07, respectively; both P < 0.001). Splenomegaly in children and anaemia were common morbidities
attributable to malaria.
conclusions Malaria prevalence across PNG is again at levels comparable to the 1970s. The strong
association of LLIN use with reduced parasitaemia supports efforts to achieve and maintain high
country-wide coverage. P. vivax infections will require special targeted approaches across PNG.
keywords Insecticide-treated Bednets, falciparum malaria, vivax malaria, Papua New Guinea,
Surveys
Introduction
Over 60% of the 7 million people of Papua New Guinea
(PNG) live in areas where malaria transmission is ende-
mic, while most of the remaining population occupies
potentially epidemic-prone areas [1, 2]. Due to the coun-
try’s proximity to the equator, malaria transmission is
influenced mainly by altitude [1], but small-area varia-
tions in endemicity are common [3, 4]. Areas of perennial
transmission can be found in coastal lowlands and
islands, while unstable transmission with localised
epidemics is common at altitudes between 1300 and
1600 m. Above 1700 m, transmission has been
considered unlikely or absent [1]. Plasmodium falciparum
and P. vivax are encountered most frequently and both
species have been associated with severe disease in chil-
dren [5]; P. malariae and P. ovale are present but these
days found only rarely [1, 4]. The mosquitoes of the
Anopheles punctulatus group are the principal vectors
but several other species with considerable differences in
ecology and transmission potential are also abundant [6].
Malaria control programmes have heavily influenced
the epidemiology of malaria in PNG since the end of
World War II. An elimination campaign based chiefly on
mass drug administration, environmental management
and indoor residual house spraying (IRS) with
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dichloro-diphenyl-trichloroethane (DDT) in the 1960s
and 1970s [7] led to initial reductions in anopheline
populations and parasite prevalence in some communities
[8]. However, the aim of eliminating malaria from PNG
was abandoned in 1972 as a result of operational chal-
lenges [9]. DDT spraying remained a major method of
control until the mid-1980s when IRS was stopped and
the responsibility for malaria control transferred to the
provinces [10].
Increasing resistance of malaria parasites to commonly
used drugs became evident with the first cases of chloro-
quine (CQ)-resistant falciparum malaria reported in 1976
[11]. This progressed rapidly to widespread CQ and
amodiaquine (AQ) resistance of P. falciparum by the
mid-1990s [1], while both drugs retained a considerable
degree of efficacy against P. vivax until the early 2000s
[12]. In studies conducted between 2003 and 2007, com-
bination regimens of CQ/AQ plus sulphadoxine–pyri-
methamine (SP) faced up to 29% in vivo resistance of
P. falciparum and 23% of P. vivax after PCR-correction
[13–15] hampering the effectiveness of malaria control.
Before intensive control began in the early 1960s,
P. vivax was the generally predominant species, followed
by P. falciparum and P. malariae both in the lowlands
[16] and in the highlands where seasonal low level trans-
mission and regular epidemics with significant morbidity
and mortality occurred [17, 18]. IRS appeared to increase
P. vivax predominance up to the 1970s [16, 19] as the
shorter extrinsic cycle, rapid gametocytaemia and long-
lasting liver stages made it more difficult to interrupt
P. vivax transmission [1, 20]. The cessation of IRS and
the emergence of drug resistance [11] led in parts to a
massive resurgence of P. falciparum contributing to a
shift from P. vivax to P. falciparum predominance [19,
21–23]. Changes in drug use may also have contributed
to this development. In some areas, in which spraying
was delayed, mass drug administration (mainly chloro-
quine and pyrimethamine) shifted the balance to P. falci-
parum even before initiation of vector control [24]. At
the end of the 1990s, P. falciparum was reported to be
predominant throughout the country with the exception
of very low-endemic highland areas, where P. vivax
remained the main species of endemic transmission but
P. falciparum the main cause of malaria epidemics [4,
25–27].
In 2004, PNG secured a grant from the Global Fund to
Fight AIDS, Tuberculosis and Malaria that allowed the
first country-wide free distribution of long-lasting insectici-
dal nets (LLIN). Over the course of 5 years, 2.3 million
LLINs were distributed to households across PNG on a
district-by-district basis, resulting in 65% household own-
ership and 33% use of LLINs country-wide [28]. A subse-
quent Global Fund Round 8 grant has been supporting the
continued free LLIN distribution since 2009 and the roll-
out of artemisinin-based combination therapy and a test-
and-treat policy since 2012 [29].
This study assessed the prevalence of Plasmodium spp.
parasitaemia in villages across PNG following the first
country-wide free LLIN distribution (2005–2008). During
the era of the global malaria eradication campaign of the
1950s to early 1980s, malaria surveys were carried out
across PNG. After the cessation of the programme, sys-
tematic prevalence surveys were conducted primarily as
part of research studies, for example in the Maprik area
[23, 30, 31], around Madang [22], or across the high-
lands in preparation for renewed IRS [4]. The survey pre-
sented here provides for the first time since cessation of
intensive control data on malaria prevalence from across
PNG, complementing the highlands malaria surveys of
the early 2000s [4] and allowing comparisons with his-
torical and future prevalence assessments.
Methods
Study sites
In the frame of the evaluation of the PNG national
malaria control programme, a household survey was
undertaken in sixteen of twenty provinces between Octo-
ber 2008 and August 2009 [28]. In 14 provinces, two dis-
tricts already covered by the free LLIN distribution
campaign were randomly selected; in two provinces, only
one district was eligible for selection. Per district, two vil-
lages were randomly sampled from a georeferenced list of
census villages [32]. Within each village, 30 households
were randomly selected by the survey team leader from a
list of all households ad hoc upon arrival. In villages with
less than 30 households, all were included. In addition,
the survey extended to 19 villages in six purposively
selected sentinel sites, which had not yet been covered
with the net distribution campaign. In each site, 3–4 vil-
lages were randomly sampled from the catchment area of
a central health facility.
Data collection
An abridged household head questionnaire following the
Malaria Indicator Survey template [33] was applied to
record demographic details of all members of sampled
households alongside information on malaria control
intervention coverage [28]. Village locations and altitudes
were recorded using hand-held GPS devices (Garmin
etrex, Garmin Ltd., Olathe, KS, USA). Capillary blood
samples were collected by finger stick from all available
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and consenting household members above 5 months of
age. One thick and one thin blood film were prepared on
the same glass slide for each participant. An additional
dry blood spot was prepared on a Whatman 3 MM filter
paper, whenever possible, and stored in individual plastic
zip bags with desiccant silica gel. Symptomatic household
members were diagnosed using a malaria rapid diagnostic
test (ICT Combo, ICT Diagnostics, Cape Town, South
Africa), and positive cases were treated according to stan-
dard treatment guidelines [34]. Haemoglobin levels were
measured with a portable HemoCue Hb 201+ photomet-
ric analyser (HemoCue AB, €Angelholm, Sweden) and
axillary temperature with an electronic thermometer. A
short questionnaire eliciting information on previous
malaria treatment and recent travel was administered to
each participant.
Malaria diagnosis
Thin films were first fixed with methanol and thick and
thin films stained with Giemsa. Thick and thin films were
read by light microscopy independently by two micro-
scopists at the PNG Institute of Medical Research. Dis-
cordant results were read by a third senior microscopist.
A minimum of 200 thick film fields were read before a
slide was declared negative. The number of parasites was
counted until reaching 200 white blood cells. Densities
for each species and for P. falciparum gametocytes were
converted to the number of parasites per microlitre of
blood assuming 8000 white blood cells per microlitre. In
case of more than two discordant species read results, the
species diagnosis was confirmed using a semi-quantitative
post-polymerase chain reaction, ligase detection reaction/
fluorescent microsphere assay described in more detail
elsewhere [31, 35, 36]. DNA for the assay was extracted
from the dried blood spot samples using the DNeasy
Blood and Tissue Kit (Qiagen, Valencia, USA) or the
Favorgen 96-Well Genomic DNA Kit (Favorgen Biotech
Corp., Taiwan) following the manufacturer’s protocols.
Data analysis
A microscopy slide was considered positive if at least two
microscopists found parasites. Species-specific results are
based on at least two concordant species identifications
(microscopy or PCR), and densities are averaged values
of concordant microscopy reads. For national and regio-
nal estimates, sampling weights were applied, calculated
as the inverse of a person’s probability of selection, as
described in more detail elsewhere [28]. For aggregated
subnational estimates, age-standardised prevalence was
calculated to account for differences in age distribution
between survey locations and the association between age
and prevalence. Age standardisation is based on the
INDEPTH standard population for Asia [37], which most
closely resembles the age distribution found in this sur-
vey. Parasite prevalence results are presented separately
for the national survey and the sentinel sites, accounting
for differences in sampling approaches, while both data
sets were pooled for the analysis of predictors of infection
and associated morbidity. Splenomegaly was defined as
palpable spleen in individuals aged 2–9 years (Hackett
score 1–5) and anaemia in accordance with WHO defini-
tions applying age group-specific cut-offs and altitude
adjustment [38].
All statistical analyses were carried out using Stata 12
(StataCorp LP, College Station, USA) software. Cluster-
ing was accounted for by applying the – svy – command
set in Stata [39]. Chi-squared tests and logistic regression
were used to compare binary outcomes and analyses of
variance and linear regression for continuous measures.
Nonparametric Mann–Whitney U-tests were used to
compare the distributions for non-normally distributed
data or unequal standard deviations. The malaria attribu-
table fraction of clinical presentations in parasitaemic
individuals was calculated as (OR1)/(OR)*100 and the
population malaria attributable fraction as (Pe(OR1))/
(1+(Pe(OR1)))*100, where Pe is the proportion para-
sitaemic in individuals without the respective symptom.
Ethics
Ethical clearance for this survey was granted by the PNG
Medical Research Advisory Committee (MRAC No.
07.30, 30 November 2007).
Results
Survey sample
A total of 49 villages located in sixteen provinces across
all four geographical regions were surveyed. Forty-four
villages (90%) were found at altitudes <1000 m, one
(2%) at 1200–1399 m, two (4%) at 1400–1599 m and
two (4%) at ≥1600 m. Blood samples were collected
from 6,646 individuals (Table S1), 52% of whom were
female. There was a significant deficit of females among
participants aged 1–15 years (48%, P < 0.001) and an
excess among adults 20–39 years (58%, P < 0.001).
An additional 19 villages were surveyed in six sentinel
sites (four in Yapsie and three in each of the other sites).
Fifteen of these villages were located below 1000 m alti-
tude; in Tabibuga, two villages were located at 1200–
1399 m and one at 1300–1500 m; in Mumeng, one
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village was located at 1400–1599 m. A total of 2290
individual blood samples were collected (Table S2), 52%
of which were from female participants. Across all sites,
an excess of female participants was found in the age
group 15–19 years (62%, P = 0.010).
Across the two data sets, 8936 slides were diagnosed
by at least two microscopists. Species-specific results were
not available for 148 slides.
Prevalence of parasitaemia
The weighted overall parasite prevalence in the national
sample amounted to 12.1% (95% CI 9.5, 15.3), with
7.0% (95% CI 5.4, 9.1) prevalence of P. falciparum,
3.8% (95% CI 2.4, 5.7) P. vivax, 0.3% (95% CI 0.1,
0.6) P. malariae, no P. ovale and 0.4% (95% CI 0.2,
0.7) P. falciparum/P. vivax mixed infections. P. falci-
parum gametocytes were found in 1.5% (95% CI 0.9,
2.4) of all samples. In infected individuals, parasite den-
sity per ll of blood ranged from 40 to 119 760 (geomet-
ric mean [GM] 974, 95% CI 816, 1163) for
P. falciparum infections, from 40 to 115 173 (GM 575,
95% CI 468, 707) for P. vivax and from 80 to 5680
(GM 904, 95% CI 532, 1538) for P. malariae. The den-
sity of P. falciparum gametocytes found in 111 blood
samples ranged from 40 to 4540 (GM 279, 95% CI 224,
348).
Age-standardised village parasite prevalence in the
national survey sample ranged from 0% in six villages
to 49.7% (median 4.9%, IQR 1.2, 14.6) (Figure 1),
with a maximum of 24.6% P. falciparum (median
2.6%, IQR 0.8, 10.1), 24.0% P. vivax (median 0.9%,
IQR 0.0, 3.8) and 2.7% P. malariae (median 0%, IQR
0.0, 0.0). The highest prevalence was found in the
Islands region (16.7%; 95% CI 15.2, 18.1), followed
by Southern (8.3%; 95% CI 7.2, 9.3), Momase (7.3%;
95% CI 5.8, 8.7) and Highlands (3.5%; 95% CI 2.0,
4.9), yet with considerable heterogeneity within the
regions (Figure 1 & Table 1). P. falciparum was the
exclusive or dominant species in 30 villages, while
P. vivax was exclusive or dominant in eleven. Preva-
lence by individual survey location is provided as sup-
porting information (Table S3).
Age-standardised prevalences found in the six sentinel
sites are presented in Table 2. Prevalence was highest in
Yapsie (34.9%; 95% CI 31.0, 38.9), followed by Sausi
(10.8%; 95% CI 6.8, 14.8), Mumeng (10.8%; 95% CI
6.9, 14.7), Tabibuga (9.3%; 95% CI 6.0, 12.6), Fin-
schhafen (8.2%; 95% CI 5.7, 10.6) and Wipim (0.8%;
95% CI 0.0, 1.6). P. falciparum was the dominant para-
site in all sentinel sites, followed by P. vivax and
P. malariae (found in three sites).
Predictors of village-level prevalence
Age-standardised village parasite prevalence on its own
was not significantly associated with altitude (t = 1.07,
P = 0.29) or altitudinal zones (as defined earlier; F
(3,64) = 0.56, P = 0.64). The small number of villages
(N = 9) surveyed at >1000 m altitude limited the extent
to which the effect of altitude could be investigated. In a
multivariate model including altitude (below/above
1000 m), proportion of LLIN users and national vs. sen-
tinel site sample, increased LLIN use (b = 0.18,
P = 0.006) and altitude above 1000 m (b = 9.44,
P = 0.03) were associated with reduced malaria preva-
lence. There was no difference in village prevalence
between national and sentinel site samples (P > 0.05)
beyond that explained by the other predictors. Effect
sizes were similar for P. falciparum (LLIN b = 0.08,
P = 0.05; altitude 1000 m b = 4.55, P = 0.08) and
P. vivax (LLIN b = 0.07, P = 0.04; altitude 1000 m
b = 3.14, P = 0.04).
Individual predictors of Plasmodium infection
Malaria infection was strongly age-dependent, being most
common in the age group 5–9 years (22.8%) and least
common in adults 20–39 (6.6%) and >40 years (6.4%,
P < 0.001) (Figure 2). P. falciparum peaked at age 5–
9 years (14.0%) and P. vivax at age 1–4 years (9.5%),
but differences were observed between geographical
regions. In Southern region, a later P. falciparum peak
was found at 5–9 (10.2%) and 10–14 years (10.6%), and
in the Highlands region, P. falciparum peaked at age 1–
4 years (7.1%) and P. vivax at 5–9 years (8.2%). In
Southern and Highlands regions, no infections were
found in children aged 6 months to 1 year.
In a multivariable model, age, altitude and mosquito
net use were all independently associated with malaria
infection (Table 3). At the time of the survey, all villages
in the national survey sample but not those in sentinel
sites had been covered by a free LLIN distribution cam-
paign [28]. Across the national survey villages, 33% of
study participants had slept under a LLIN the previous
night, whereas in sentinel sites, only 5% had. Individual
use of an LLIN the previous night and high community-
wide use were both independently associated with signifi-
cantly reduced odds of infection (OR = 0.64 and
OR = 0.07, respectively; Table 3). The self-reported
recent intake of an antimalarial medicine did not lower
the odds of infection but was associated with a twofold
increase in the case of P. falciparum infection. Living in
sentinel site villages (pre-LLIN distribution) was associ-
ated with increased odds of parasitaemia in general
1748 © 2015 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd.
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(Table 3) and with P. malariae infection in particular
(OR = 2.23, 95% CI 1.11, 4.50, P = 0.02). P. malariae
infections were not associated with altitude or LLIN use.
Morbidity associated with infection
Of all survey participants, 12.5% reported a recent epi-
sode of fever (last 2 days), while 3.4% had axillary body
temperature of >37.5 °C at the time of the survey
(Table 4). Acute measured fever was more strongly asso-
ciated with malaria infection than a self-reported recent
fever episode (OR = 4.8 vs. OR = 2.1) and more cases of
measured fever than of reported episodes in the popula-
tion could be attributed to malaria infections. At higher
altitudes (1400–1599 m), reported fever episodes were
more likely associated with malaria infection than in low-
land areas (<1000 m) (OR = 5.7, vs. OR = 2.0,
v23df = 7.84, P = 0.049).
The mean Hb (SD) was 11.7  2.0 in males and
11.0  1.7 in females (Wilcoxon rank-sum z = 15.49,
P < 0.001) and differed significantly between pregnant
and non-pregnant women aged 15–49 years (10.1  1.6
vs. 11.4  1.7, t = 8.56, P < 0.001). Of all participants,
67.9% were anaemic (56.1% in males, 69.7% in females,
v21df = 12.5, P < 0.001) and 6.1% (95% CI 5.6, 6.6)
had moderate-to-severe anaemia (Hb < 80 g/l;
Hb < 70 g/l in children <5 years and pregnant women).
Anaemia was significantly associated with malaria infec-
tion (OR = 2.6, severe anaemia OR = 1.8) but in the
context of high overall prevalence, only 10% of anaemia
cases in the community could be attributed to a concur-
rent Plasmodium spp. infection (Table 4).
In children 2–9 years, 18.8% had a palpable spleen
(3.4% had moderate to massive splenomegaly, Hackett
score 3–5) with no differences between sexes, but strong
association with malarial infection (OR = 5.6; Table 4).
In the Islands region, this correlation was weaker
(OR = 2.9, 95% CI 2.1, 4.0) with more uninfected indi-
viduals having an enlarged spleen (19.0% in Islands vs.
8.6% in other regions, v21df = 48.1, P < 0.001). In one
village in New Ireland Province (Islands region), 55.2%
of all children had an enlarged spleen. Most enlarged
spleens in children infected with malarial parasites could
be attributed to this infection (MAF = 82.0%) and 43%
of all cases of splenomegaly in the population could be
attributed to malaria. The association was stronger in
children 1–4 years (OR = 13.1, 95% CI 8.7, 19.9) than
in the other age groups (test of homogeneity,
v26df = 46.45, P < 0.001).
Discussion
The wealth of historical malaria data from PNG, some of
it dating back to Robert Koch’s expedition to German
New Guinea in 1900 [40], calls for an assessment of
trends over time. Considering small-area variations in
transmission, direct comparisons are somewhat con-
strained by the different geographical ranges and uncer-
tainties with regard to the sampling methodology in
previous ‘mass blood surveys’. This survey confirms
Table 1 Age-standardised provincial and regional parasite
prevalence
Province/Region N
Age-standardised
prevalence (%)
All P.f. P.v. P.m.
1 Western 244 0.0 0.0 0.0 0.0
2 Gulf 517 1.3 1.1 0.0 0.0
3 Central 613 1.4 0.5 0.7 0.0
4 National Capital District 0
5 Milne Bay 305 9.2 6.2 1.5 0.0
6 Oro 775 20.7 15.5 2.9 0.7
Overall Southern region 2454 8.3 6.0 1.3 0.2
7 Southern Highlands 0
8 Enga 0
9 Western Highlands 143 4.9 3.4 1.5 0.0
10 Chimbu 0
11 Eastern Highlands 457 3.1 1.1 0.9 0.2
Overall Highlands region 600 3.5 1.6 1.1 0.1
12 Morobe 489 4.4 3.8 0.2 0.0
13 Madang 264 18.4 7.8 2.5 1.5
14 East Sepik 254 2.0 0.5 0.6 0.0
15 Sandaun 167 4.8 4.8 0.5 0.0
Overall Momase region 1174 7.3 4.1 0.9 0.3
16 Manus 303 9.0 6.0 2.7 0.0
17 New Ireland 439 16.2 11.2 3.6 1.3
18 East New Britain 443 11.4 6.8 3.2 0.8
19 West New Britain 722 30.8 16.7 12.6 0.3
20 Bougainville 511 7.6 2.1 3.8 0.1
Overall Islands region 2418 16.7 9.2 6.2 0.4
Table 2 Age-standardised parasite prevalence in sentinel sites
Province Sentinel site N
Age-standardised
prevalence (%)
All P.f. P.v. P.m.
Western Wipim 368 0.8 0.5 0.3 0.0
Western
Highlands
Tabibuga 324 9.3 5.2 2.4 1.2
Morobe Finschhafen 451 8.2 4.3 2.9 0.4
Morobe Mumeng 279 10.8 7.6 3.1 0.0
Madang Sausi 334 10.8 5.8 3.4 0.0
Sandaun Yapsie 534 34.9 16.8 9.2 1.7
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substantial heterogeneity in the prevalence of malaria
across PNG with marked differences even between
nearby villages (Figure 1 and Table S3). Previously, these
had been attributed to entomological factors, the use of
antimalarials and mosquito nets, and the abundance of
alternative hosts [3, 41]. With raising coverage under the
current control programme [42], the use of mosquito nets
may play an increasingly important role in determining
heterogeneity.
Prior to intensified control in the 1960s, malaria was
endemic throughout the lowlands provinces of PNG with
high prevalence of infection and splenomegaly [7]. The
2008/2009 survey found major differences between parts
of Southern region (Southern parts of Western Province
to Central), where prevalence was very low, and the
remaining lowlands provinces, where clusters of higher
prevalence (>20%) were found. In the South and Middle
Fly of Western Province, in Gulf and Central, spleen rates
of 100% and parasite prevalence of >50% in children
younger than 5 years were common in the pre-control
era [41]. A reduction to <5% overall parasite prevalence
was documented in Central Province in the early 1970s
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by geographical region.
Table 3 Multivariable analysis of predictors of malaria infection
Predictors
Any infection P. falciparum P. vivax
OR 95% CI P OR 95% CI P OR 95% CI P
Altitude
>1000 m 0.36 (0.27, 0.47) <0.001 0.37 (0.25, 0.53) <0.001 0.36 (0.22, 0.58) <0.001
Age (years)
<1 1.10 (0.47, 2.58) 0.54 (0.13, 2.26) 3.61 (1.21, 10.72)
1–4 3.98 (3.12, 5.06) 2.76 (2.03, 3.76) 7.84 (4.98, 12.35)
5–9 4.52 (3.58, 5.69) 4.03 (3.02, 5.38) 5.66 (3.58, 8.93)
10–14 3.24 (2.52, 4.16) 3.02 (2.21, 4.14) 2.77 (1.65, 4.66)
15–19 1.70 (1.24, 2.32) 1.75 (1.19, 2.58) 1.29 (0.64, 2.60)
20–39 1.07 (0.83, 1.37) 0.91 (0.66, 1.26) 1.11 (0.66, 1.87)
40+ 1 <0.001 1 <0.001 1 <0.001
LLIN use 0.64 (0.54, 0.76) <0.001 0.76 (0.62, 0.93) 0.02 0.54 (0.40, 0.72) <0.001
High LLIN use in village* 0.07 (0.03, 0.19) <0.001 0.09 (0.03, 0.27) <0.001 0.39 (0.25, 0.61) <0.001
Antimalarial 2 days 2.02 (1.03, 3.94) 0.04
Sentinel site survey 1.23 (1.06, 1.42) <0.001
*80% for any infection and P. falciparum, 50% for P. vivax. No P. vivax-infected individuals were found in villages with 80% use.
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following scaling up of IRS [7]. Samples collected from
these provinces in 2008/2009 revealed once again similar
levels of prevalence: In Western province, none of the
244 blood samples collected in post-LLIN campaign vil-
lages was positive, and in the Wipim sentinel site, pre-
LLIN prevalence was only 0.8%. Low endemicity in this
area was also confirmed in clinical cases [43]. In neigh-
bouring Gulf and Central provinces, the majority of vil-
lages had <1% overall prevalence. In the same region,
average parasite prevalence remained higher in Milne Bay
(12.9%) and in Oro (31.1%), yet still below pre-control
levels; in Milne Bay, prevalence was comparable to the
1970s. A direct comparison of Kiriwina (Trobriand
Islands, Milne Bay) illustrates how individual locations
may have followed different trends: overall prevalence
1.6% in 1966 and 10.6% in 2008/2009. In Oro, 10%
prevalence was initially achieved with IRS in 1970, but
the gains could not be sustained [7].
Morobe, Madang, East Sepik and West Sepik (San-
daun) Provinces (Momase region) were areas of high
endemicity, documented as early as 1900 [40]. In
Madang, pre-control prevalence of 24.9% (1960) was
recorded by Parkinson [7], while for some places, >40%
and >70% in children (e.g. Utu) were documented [41].
In the Maprik area (East Sepik), prevalence reached
nearly 90% in children, triggering a pilot IRS campaign
in 1957 [7]. Major gains were recorded in the 1960s
reducing prevalence to <8% in Madang and Morobe and
from 75% to <17% in East Sepik [7]. In a study con-
ducted near Madang in the early 1980s, prevalence var-
ied from 35% to 43% [22], and in the Maprik area, it
reached 60% in the early 1990s [23] but subsequently
dropped [44]. Compared to the 1970s, 2008/2009 preva-
lence was again higher in the Madang province (up to
34.1%) and largely unchanged in Morobe. Results for
East Sepik should be interpreted with caution as the
Maprik area was excluded from this survey due to other
ongoing field research activities [45]. In villages of the
Yapsie(i) sentinel site in West Sepik (Sandaun), preva-
lence ranged from 27.1% to 42.2% (spleen rates reached
>80%), illustrating high malaria endemicity and confirm-
ing earlier reports (1986) from this remote part of PNG
[46].
High malaria prevalence was also found in villages of
the Islands region, particularly in the province of West
New Britain (up to 49.7%). Documented average pre-
control prevalence in the Islands region ranged from
10.3% in New Ireland to 44.9% in West New Britain.
Intensive control in the 1960s resulted in reductions in all
Islands provinces to <10% in the early 1970s, except in
West New Britain, where it remained between 20% and
30% [7, 41]. The 2008/2009 prevalence in these pro-
vinces is lower than before the start of intensive control
but has increased again since the 1970s, most markedly
in West New Britain Province.
Highlands provinces were not extensively surveyed
(Tables S1, S2) because of data available from previous
surveys. Betuela et al. [4] reported that malaria endemic-
ity in the early 2000s was comparable to the situation in
the 1950s–1960s and the highlands point estimates in the
2008/2009 survey confirm this observation. Certain
results for this region, such as prevalence by age (Fig-
ure 2) should be interpreted with caution due to the lim-
ited number of survey points. Across PNG, peak
prevalence of infection with P. falciparum was found in
the age group 5–9 years and with P. vivax in the age
group 1–4 years. In the Highlands region, this situation
was reversed, while in Southern region, where overall
prevalence was lowest, the peak prevalence of P. falci-
parum was shifted even further to 10- to 14-year-olds. It
was not possible in this survey to identify an increase in
P. vivax dominance with increasing altitude. Much rather
were P. falciparum and P. vivax infections present
throughout the country with no clear geographical prefer-
ence. The most marked P. vivax dominance was found in
villages of New Britain and Bougainville in the Islands
Table 4 Morbidity associated with malarial infection
Morbidity N
% with symptom
(95% CI)
% with symptom in
infected (95% CI) OR (95% CI) P
MAF %
(95% CI) PMAF %
Fever 37.5 °C 8732 3.4 (3.1, 3.8) 10.4 (8.6, 12.3) 4.8 (3.7, 6.1) <0.001 79.0 (73.1, 83.6) 31.4
Reported recent
fever*
8771 12.5 (11.8, 13.2) 21.0 (18.7, 23.5) 2.1 (1.8, 2.5) <0.001 52.7 (44.3, 59.7) 11.6
Anaemia 8185 67.9 (66.9, 68.9) 83.2 (81.0, 85.4) 2.6 (2.2, 3.1) <0.001 61.7 (54.8, 67.6) 10.4
Severe anaemia 8185 6.1 (5.6, 6.6) 9.5 (7.8, 11.2) 1.8 (1.4, 2.2) <0.001 43.9 (29.2, 55.3) 9.4
Splenomegaly
(age 2–9 years)
2825 18.8 (17.4, 20.3) 42.4 (38.6, 46.3) 5.6 (4.5, 6.9) <0.001 82.0 (77.9, 85.4) 42.8
*Previous 2 days; MAF, malaria attributable fraction; PMAF, malaria attributable fraction in population.
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region. P. malariae was most frequently found in the
Islands region, while no P. ovale infection was identified
in the survey samples, confirming previous findings that
this species was rare [22, 41, 47].
Age, altitude, individual use of an LLIN as well as high
community LLIN coverage were independently and
strongly associated with reduced odds of malaria infec-
tion. Interestingly, this association of LLIN use was
observed with infections of both P. falciparum and P. vi-
vax, while previous surveys in the highlands suggested an
association exclusively with P. falciparum infection [4].
The finding was further supported by the observation
that pre-LLIN distribution surveys in sentinel sites found,
with few exceptions, higher prevalence than in surround-
ing areas of the same provinces, where LLIN had already
been distributed. Recent intake of an antimalarial medi-
cine may be expected to be a predictor of less para-
sitaemia (assuming drugs were effective), but the opposite
was the case for P. falciparum, suggesting that the recent
treatment was in fact a result of a malarial infection and
most likely a clinical episode.
The most important pattern of morbidity found during
this survey was the high level of anaemia in the population
(61.7% when applying WHO thresholds [38]). Even
though severe anaemia was less common, the prevalence
of anaemia in the general population would be considered
a severe public health problem [38]. According to this sur-
vey, only 12% of anaemia cases in the community can be
attributed to malarial infection and while recently cleared
infections may contribute a further portion, significant
additional risk factors for anaemia must be present in the
population [48, 49]. Palpable spleen (Hackett score 1–5)
was found in 19% of children age 2–9 years, and most of
these cases could be attributed to a malarial infection.
Other factors affecting the spleen were not investigated.
Methodological considerations
This survey included sites from across PNG yet excluding
many highlands areas and villages in East Sepik province
(where other studies were carried out at the time of the
survey). The national level data were derived from vil-
lages in districts previously covered with an LLIN distri-
bution campaign, which should be taken into
consideration in the interpretation of the results. The
strong association of parasite prevalence with age and the
differences in age distributions between survey locations
demand for an age standardisation of prevalence results
to allow unbiased comparisons between sites. Age stan-
dardisation has not commonly been performed in reports
from other (historical and contemporary) surveys, which
should be considered in the direct comparison of results.
Double-read microscopy with a confirmatory third read
in case of discordant pairs has not resulted in conclusive
species identifications in 192 cases. PCR data were avail-
able to confirm the species of 44 of these samples, while
the remaining 148 discordant results could not be con-
firmed. This approach provided more accurate results
than the single-read diagnostic which has been applied in
many historical studies or in those relying on routinely
collected diagnostic data.
Seasonal weather patterns influence malaria transmis-
sion, incidence of clinical episodes, but to a lesser extent
prevalence of infection [50]. While including this factor
in the analysis of predictors of infection would have been
desirable, no sufficiently reliable weather data were avail-
able. As prevalence has been shown to vary less over the
year [50], a major bias of the results would not be
expected.
Conclusions
Following the first large-scale distribution of LLIN,
malaria prevalence across PNG is comparable to the
levels achieved during the 1970s with DDT-spraying
campaigns. The strong association of LLIN use and
reduced parasitaemia supports efforts to achieve high
LLIN coverage across PNG. A further reduction in popu-
lation parasite prevalence can be expected if usage levels
increase. The presence of P. vivax across the country will
require special attention and targeted approaches, partic-
ularly with regards to the treatment of infections. Contin-
uous monitoring of prevalence and incidence rates at a
national level will provide useful evidence of the impact
of the intensified malaria control efforts in PNG.
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